GlassScriptPhysician profile
John R Coleman
NPI 1902854060
$3,794.01
in general payments reported to CMS, 2019-2025
26 companies · $988 in 2025
The $988 reported for 2025 was more than what 79% of Otolaryngology providers received nationally (typical 2025 total: $317).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $386 · 2020: $131 · 2021: $604 · 2022: $528 · 2023: $760 · 2024: $397 · 2025: $988.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,112 · Education: $34.00.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,111.53 |
| Education | $34.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Regeneron Healthcare Solutions, INC. | $638.25 | 2019-2025 | Dupixent |
| Genzyme Corporation | $515.92 | 2019-2025 | |
| Merz North America, INC. | $458.03 | 2019-2023 | Xeomin |
| Optinose US, INC. | $367.10 | 2019-2025 | |
| Glaxosmithkline, LLC. | $275.87 | 2021-2025 | Nucala |
| Abbvie INC. | $223.61 | 2023 | Botox |
| Integra Lifesciences Corporation | $164.79 | 2021-2025 | Relieva Spinplus Nav, Trudi Probe, Inspira Air |
| Aerin Medical INC. | $150.65 | 2019-2024 | |
| Astrazeneca Pharmaceuticals LP | $134.55 | 2025 | |
| Kaleo, INC. | $107.07 | 2019-2023 | Auvi-Q |
| Stryker Corporation | $96.75 | 2019-2022 | |
| Hikma Pharmaceuticals USA | $89.34 | 2022-2024 | Ryaltris |
| Allergan, INC. | $89.29 | 2021-2022 | |
| Intersect Ent, INC. | $85.95 | 2019-2021 | |
| Amgen INC. | $83.33 | 2020-2025 | Tezspire |
Show all 26 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Alk-Abello, INC | $65.22 | 2019-2022 | |
| Acelrx Pharmaceuticals, INC. | $47.09 | 2021-2022 | |
| Acclarent, INC | $45.34 | 2019-2021 | |
| Ars Pharmaceuticals Operations, INC. | $28.64 | 2025 | Neffy |
| Medtronic, INC. | $24.96 | 2024 | Sinuva |
| Merck Sharp & Dohme LLC | $21.10 | 2023 | |
| Inspire Medical Systems, INC. | $18.73 | 2025 | Inspire |
| Novartis Pharmaceuticals Corporation | $18.05 | 2019 | |
| Phadia US INC. | $15.13 | 2021 | |
| Aytu Biopharma, INC. | $15.03 | 2021 | |
| Olympus America INC. | $14.22 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw John Coleman listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.